Teva Pharmaceutical is considering a takeover bid for drug maker Mylan, a sign of the jockeying for dominance among generic drug makers.
from WSJ.com: US Business http://ift.tt/1aE8Mg5
via IFTTT
from WSJ.com: US Business http://ift.tt/1aE8Mg5
via IFTTT
No comments:
Post a Comment